Removing vs. Cutting Ovarian Cancer from the Bowel
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study compares two surgical approaches for removing advanced ovarian cancer that has attached to the rectosigmoid (lower bowel). Both methods aim to remove the cancer safely, but this trial tests whether one approach works as well as the other.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced epithelial ovarian cancer (stage IIB or higher) needing surgery for the first time
- You are 18–70 years old and in generally good health (ECOG score below 3)
- Your colonoscopy shows the cancer has not invaded the bowel lining itself
- MRI imaging confirms the tumor involves the bowel surface or nearby tissue (mesentery)
- You can tolerate surgery safely (ASA score below 3)
- You have not had prior abdominal or pelvic radiation therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical options for ovarian cancer that involves the rectosigmoid bowel wall: removing a segment (resection) versus shaving only the involved layer (tumor shaving). It may help find which approach is safer and better for people whose cancer has spread to the outer bowel layers.
This trial tests whether doing surgery with small incisions (minimally invasive) instead of a large cut is safe and effective for advanced ovarian cancer after chemo. It may mean a faster recovery while still removing the cancer.
This study looks at how well a minimally invasive surgery (laparoscopic debulking) can remove tumor in people with advanced epithelial ovarian cancer. It may help doctors compare whether this approach is safe and effective for patients who need either upfront surgery or surgery after chemotherapy.
This trial studies whether doing surgery using smaller incisions after chemotherapy works as well as a more traditional approach for certain people with stage IIIC–IV ovarian, fallopian tube, or primary peritoneal cancer. It may help reduce surgical trauma while aiming for effective tumor removal.
This study explores an alternative method to the previous approach of whether to bypass or not? or wait... it's about the use of something? wait... the title is... wait? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? you get the idea? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?until? ?title? ?title? ?title? ?title? ?title? flask? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ? what? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ? ???????????????
This trial studies how patients’ day-to-day quality of life changes after a specific type of rectal/low anterior resection during treatment for advanced ovarian cancer. It may help the medical team understand what symptoms and recovery needs to expect after surgery.
Hear when a new Ovarian Cancer (OvCa) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.